BZPEERReading, trust and collaboration for research
Menu

Discover

GraphFollow connections around a paper, topic or saved view.

Workspaces

HomePick up where your research flow left off.InboxHandle requests, replies and notifications from one place.CollectionsCurate reading lists, evidence sets and shareable dossiers.ResearchSee your private provenance graph, trail and imports.CollaborationMove from discovery into focused discussion rooms.PublishDraft, preview and publish full-text research articles.

Network

ExpertsFind specialists worth following or asking for help.CommunitiesJoin research circles organized around shared work.PartnersSee external organizations active around the same topics.

Opportunities

ListingsBrowse roles, calls and collaborations with clearer fit signals.

Account

Log inReturn to your reading and collaboration workspace.Create accountStart saving work, following people and joining teams.
Log inCreate account

Researcher profile

Menggang Yu

Menggang Yu contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate
MethodologyApplicationsMachine Learning

Trust snapshot

Quick read

Trust 19 - UnverifiedVerification L1Unclaimed author
5works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

5 published item(s)

preprint2022arXiv

Entropy Balancing for Causal Generalization with Target Sample Summary Information

In this paper, we focus on estimating the average treatment effect (ATE) of a target population when individual-level data from a source population and summary-level data (e.g., first or second moments of certain covariates) from the target population are available. In the presence of heterogeneous treatment effect, the ATE of the target population can be different from that of the source population when distributions of treatment effect modifiers are dissimilar in these two populations, a phenomenon also known as covariate shift. Many methods have been developed to adjust for covariate shift, but most require individual covariates from a representative target sample. We develop a weighting approach based on summary-level information from the target sample to adjust for possible covariate shift in effect modifiers. In particular, weights of the treated and control groups within a source sample are calibrated by the summary-level information of the target sample. Our approach also seeks additional covariate balance between the treated and control groups in the source sample. We study the asymptotic behavior of the corresponding weighted estimator for the target population ATE under a wide range of conditions. The theoretical implications are confirmed in simulation studies and a real data application.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Non-convex SVM for cancer diagnosis based on morphologic features of tumor microenvironment

The surroundings of a cancerous tumor impact how it grows and develops in humans. New data from early breast cancer patients contains information on the collagen fibers surrounding the tumorous tissue -- offering hope of finding additional biomarkers for diagnosis and prognosis -- but poses two challenges for typical analysis. Each image section contains information on hundreds of fibers, and each tissue has multiple image sections contributing to a single prediction of tumor vs. non-tumor. This nested relationship of fibers within image spots within tissue samples requires a specialized analysis approach. We devise a novel support vector machine (SVM)-based predictive algorithm for this data structure. By treating the collection of fibers as a probability distribution, we can measure similarities between the collections through a flexible kernel approach. By assuming the relationship of tumor status between image sections and tissue samples, the constructed SVM problem is non-convex and traditional algorithms can not be applied. We propose two algorithms that exchange computational accuracy and efficiency to manage data of all sizes. The predictive performance of both algorithms is evaluated on the collagen fiber data set and additional simulation scenarios. We offer reproducible implementations of both algorithms of this approach in the R package mildsvm.

0 citations0 reviewsNo code linkedOpen access
preprint2022arXiv

Policy Learning for Optimal Individualized Dose Intervals

We study the problem of learning individualized dose intervals using observational data. There are very few previous works for policy learning with continuous treatment, and all of them focused on recommending an optimal dose rather than an optimal dose interval. In this paper, we propose a new method to estimate such an optimal dose interval, named probability dose interval (PDI). The potential outcomes for doses in the PDI are guaranteed better than a pre-specified threshold with a given probability (e.g., 50%). The associated nonconvex optimization problem can be efficiently solved by the Difference-of-Convex functions (DC) algorithm. We prove that our estimated policy is consistent, and its risk converges to that of the best-in-class policy at a root-n rate. Numerical simulations show the advantage of the proposed method over outcome modeling based benchmarks. We further demonstrate the performance of our method in determining individualized Hemoglobin A1c (HbA1c) control intervals for elderly patients with diabetes.

0 citations0 reviewsNo code linkedOpen access
preprint2021arXiv

Studentized Permutation Method for Comparing Restricted Mean Survival Times with Small Sample from Randomized Trials

Recent observations, especially in cancer immunotherapy clinical trials with time-to-event outcomes, show that the commonly used proportial hazard assumption is often not justifiable, hampering an appropriate analyse of the data by hazard ratios. An attractive alternative advocated is given by the restricted mean survival time (RMST), which does not rely on any model assumption and can always be interpreted intuitively. As pointed out recently by Horiguchi and Uno (2020), methods for the RMST based on asymptotic theory suffer from inflated type-I error under small sample sizes. To overcome this problem, they suggested a permutation strategy leading to more convincing results in simulations. However, their proposal requires an exchangeable data set-up between comparison groups which may be limiting in practice. In addition, it is not possible to invert their testing procedure to obtain valid confidence intervals, which can provide more in-depth information. In this paper, we address these limitations by proposing a studentized permutation test as well as the corresponding permutation-based confidence intervals. In our extensive simulation study, we demonstrate the advantage of our new method, especially in situations with relative small sample sizes and unbalanced groups. Finally we illustrate the application of the proposed method by re-analysing data from a recent lung cancer clinical trial.

0 citations0 reviewsNo code linkedOpen access
preprint2020arXiv

A Semiparametric Approach to Model Effect Modification

One fundamental statistical question for research areas such as precision medicine and health disparity is about discovering effect modification of treatment or exposure by observed covariates. We propose a semiparametric framework for identifying such effect modification. Instead of using the traditional outcome models, we directly posit semiparametric models on contrasts, or expected differences of the outcome under different treatment choices or exposures. Through semiparametric estimation theory, all valid estimating equations, including the efficient scores, are derived. Besides doubly robust loss functions, our approach also enables dimension reduction in presence of many covariates. The asymptotic and non-asymptotic properties of the proposed methods are explored via a unified statistical and algorithmic analysis. Comparison with existing methods in both simulation and real data analysis demonstrates the superiority of our estimators especially for an efficiency improved version.

0 citations0 reviewsNo code linkedOpen access